In this report, we present the first results of the Moscow cancer screening program implementation, which included 816 patients with P/LP variants in cancer-associated genes (BRCA1, BRCA2, CHEK2, PALB2, ATM, STK11, and TP53). This evidence concerns the gene ATM and cancer.